Azzad Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Azzad Asset Management's BIIB Position: Q3 2026 in Review
Azzad Asset Management increased its Biogen (BIIB) stake by 0.22% in Q3 2026, buying an estimated $1.27K and bringing the position to 2,790 shares worth $630K. The position accounts for 0.06% of the portfolio, ranked #287.
Azzad Asset Management first reported a position in BIIB in Q4 2015 and has held it in 26 quarters since. The position peaked at $2.23M in Q4 2019. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Azzad Asset Management held 2,790 shares of Biogen worth $630K as of Q3 2026.
- Azzad Asset Management bought 6 Biogen shares in Q3 2026, an estimated $1.27K.
- Biogen made up 0.06% of Azzad Asset Management's portfolio in Q3 2026, its #287 holding.
- Azzad Asset Management first reported a position in Biogen in Q4 2015 and has held it in 26 quarters since.
- Azzad Asset Management's Biogen position peaked at $2.23M in Q4 2019.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Azzad Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.